MCHFX
Price
$16.91
Change
+$0.22 (+1.32%)
Updated
Aug 28 closing price
Net Assets
400.14M
TRCLX
Price
$13.35
Change
+$0.11 (+0.83%)
Updated
Aug 28 closing price
Net Assets
59.76M
Interact to see
Advertisement

MCHFX vs TRCLX

Header iconMCHFX vs TRCLX Comparison
Open Charts MCHFX vs TRCLXBanner chart's image
Matthews China Investor
Price$16.91
Change+$0.22 (+1.32%)
VolumeN/A
Net Assets400.14M
T. Rowe Price China Evolution Equity I
Price$13.35
Change+$0.11 (+0.83%)
VolumeN/A
Net Assets59.76M
MCHFX vs TRCLX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MCHFX has more cash in the bank: 400M vs. TRCLX (59.8M). MCHFX (1.62) and TRCLX (1.56) have matching dividends . MCHFX was incepted earlier than TRCLX: MCHFX (28 years) vs TRCLX (6 years). TRCLX (2.10) is less costly to investors than MCHFX (1.25). TRCLX is a more actively managed with annual turnover of: 82.40 vs. MCHFX (49.99). MCHFX has a lower initial minimum investment than TRCLX: MCHFX (2500) vs TRCLX (500000). MCHFX annual gain was more profitable for investors over the last year : 53.61 vs. TRCLX (42.94). TRCLX return over 5 years is better than : -6.52 vs. MCHFX (-31.68).
MCHFXTRCLXMCHFX / TRCLX
Total Expense Ratio1.251.03121%
Annual Report Gross Expense Ratio1.252.1060%
Fund Existence28 years6 years-
Gain YTD24.18225.37995%
Front LoadN/AN/A-
Min. Initial Investment25005000001%
Min. Initial Investment IRAN/AN/A-
Net Assets400M59.8M669%
Annual Yield % from dividends1.621.56104%
Returns for 1 year53.6142.94125%
Returns for 3 years10.4513.4778%
Returns for 5 years-31.68-6.52486%
Returns for 10 years-7.91N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XTWY37.820.29
+0.79%
BondBloxx Bloomberg TwentyYrTrgDuUSTrETF
BYLD22.810.10
+0.44%
iShares Yield Optimized Bond ETF
PTEC39.56N/A
N/A
Global X PropTech ETF
QHY46.31-0.02
-0.03%
WisdomTree US Hi Yld Corp Bd
FBT171.75-0.32
-0.18%
First Trust NYSE Arca Biotech ETF